TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( TSX-V: ENTG ) ( OTCQX: ETRGF ) ( FSE:4WE ) (“ Entourage ” or the“ Company ”), a Canadian producer and distributor of award-winning cannabis products, today announced its financial results for the three months ended March 31, 2024. The Company reported total revenue of $16.
4 million (net revenue of $12.7 million, before excise duties and discounts), up 9% year-over-year. The Company will host a conference call to discuss its financial and business highlights on Tuesday, May 28, 2024, at 10:00 a.
m. Eastern Time. “Entourage's first quarter results are a testament to our robust financial health and strategic approach to business operations, positioning us for success throughout 2024,” said George Scorsis, Chair and CEO.
“With defined infrastructure and supply agreements in place, we are well-positioned to continue delivering the accelerated growth we have already seen develop in Q1. Our team's relentless focus on efficient execution has led to a solid performance, reflected in improved profitability and a significant increase in EBITDA, marking the first positive quarter. We are also seeing substantial growth in our adult-use business as we continue to announce and launch a range of innovative products across Canada set to generate ongoing interest and excitement among consumers.
” Summary of Results *Net revenue defined as revenue (i.e., gross revenue less discounts and customer incentives but inclu.
